✦ LIBER ✦

[578] DOES ADJUVANT THERAPY WITH ERYTHROPOIETIN AND GCSF IMPROVE SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS RECEIVING COMBINATION THERAPY WITH PEGYLATED INTERFERON AND RIBAVIRIN FOR CHRONIC HEPATITIS C?

✍ Scribed by W.J. Cash; K. Patterson; M.E. Callender; N.I. McDougall

Book ID: 117375670
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 262 KB
Volume: 46
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(07)62176-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimal follow-up time to determine the

Optimal follow-up time to determine the sustained virological response in patients with chronic hepatitis C receiving pegylated-interferon and ribavirin

✍ Masashi Namikawa; Satoru Kakizaki; Yutaka Yata; Yuichi Yamazaki; Norio Horiguchi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

Impact of ribavirin plasma level on sust

Impact of ribavirin plasma level on sustained virological response in patients treated with pegylated interferon and ribavirin for chronic hepatitis C

✍ D. BREILH; J. FOUCHER; L. CASTÉRA; P. TRIMOULET; S. DJABAROUTI; W. MERROUCHE; P. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Low dose erythropoietin-beta improves an

Low dose erythropoietin-beta improves anemia and maintains ribavirin dose in chronic hepatitis C patients receiving combination therapy with ribavirin plus pegylated interferon Alfa-2b

✍ Kuo-Chih Tseng; Li-Hsuan Chen; Chi-Yi Chen; Ting-Tsung Chang; An-Liang Chou; I-C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

Combination therapy with ribavirin and i

Combination therapy with ribavirin and interferon in naive patients with chronic hepatitis C without virological response after two months of interferon therapy. Preliminary results

✍ F Lunel; P Cresta 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Do steatosis and steatohepatitis impact

Do steatosis and steatohepatitis impact on sustained virological response (SVR) rates in patients receiving pegylated interferon and ribavirin for chronic hepatitis C infection?

✍ T.J.S. Cross; A. Quaglia; J. Nolan; S. Hughes; P.M. Harrison 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 1 views

## Abstract The impact of steatosis on treatment response in chronic hepatitis C infection is controversial. The aim of this study was to determine whether steatosis ± steatohepatitis on pre‐treatment liver biopsy influenced sustained virological response (HCV RNA negative 6 months after completing

Serum hs-CRP was correlated with treatme

Serum hs-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patients

✍ Chung-Feng Huang; Ming-Yen Hsieh; Jeng-Fu Yang; Wu-Cheng Chen; Ming-Lun Yeh; Chi 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 193 KB